Detall de la convocatòria


Objectiu de la convocatòria
Grants for innovative haemostatic research on non-interventional observational studies focusing on patient outcomes, quality of life and social impact.
Característiques principals
Areas of interest include, but are not limited to:
  • Treatment options, outcome measures, and compliance
  • Epidemiology of inhibitor development, including factors relevant to susceptibility
  • Inhibitor management issues (e.g. with focus on tolerization/immunomodulation)
  • Health economic outcomes
  • Quality of care related areas including patients’ quality of life, unmet needs, and psychosocial issues associated with the disease
  • Diagnosis and treatment of von Willebrand disease and platelet disorders
  • Investigation of joint health; prophylaxis and improvement of long-term joint health outcomes
    In order to maintain a focus on the treatment of haemophilia and other rare bleeding disorders, Access to Insight clinical research grants will not support research focused on:
  • Pathophysiology, diagnosis, and treatment of blood transmitted diseases
  • Thrombotic disorders
  • Products or technologies licensed or patented by competitors of Novo Nordiskisorders
  • Lloc de presentació
    IMIM and PSMAR staff who need more information should contact::
    Research Grants and Contracts Office. C/ Doctor Aiguader, 88. 08003-Barcelona. Tel.: 93.316.04.00.
    Carol Barnwell: Ext.: 1670
    Marta López: Ext.: 1576
    Convocatòria (URL)
    Applicants should be health care professionals providing care for haemophilia and rare bleeding disorders patients, including nurses, physiotherapists, and psychologists.
    12 months


    Novo Nordisk - Your Access to Insight - Supporting global haemostasis research.pdf